Pre‐clinical evaluation of dual targeting of the GPCRs CaSR and V2R as therapeutic strategy for autosomal dominant polycystic kidney disease

Annarita Di Mise(University of Bari Aldo Moro), Giovanna Valenti(Istituto Nazionale Biostrutture e Biosistemi)
The FASEB Journal
September 5, 2021
10.1096/fj.202100774r
Cited by 20

Related Papers

Aquaporins, Vasopressin, and Aging: Current Perspectives
|Endocrinology|2014|55
Activation of Calcium-Sensing Receptor increases intracellular calcium and decreases cAMP and mTOR in PKD1 deficient cells
|Scientific Reports|2018|48
<i>In vivo</i> treatment with calcilytic of CaSR knock‐in mice ameliorates renal phenotype reversing downregulation of the vasopressin‐AQP2 pathway
|The Journal of Physiology|2024|4